Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for 10x Genomics (TXG : NSDQ)

• Company Description    10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. Number of Employees: 473

• Price / Volume Information    Yesterday's Closing Price: $23.68 Daily Weekly Monthly 20 Day Moving Average: 2,740,359 shares Shares Outstanding: 126.96 (millions) Market Capitalization: $3,006.32 (millions) Beta: 2.05 52 Week High: $26.45 52 Week Low: $8.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 10.55% 5.15% 12 Week 7.00% -1.08% Year To Date 45.19% 39.12%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6230 STONERIDGE MALL ROAD - PLEASANTON,CA 94588 USA ph: 925-401-7300 fax: - investors@10xgenomics.com http://www.10xgenomics.com

• General Corporate Information    Officers Serge Saxonov - Chief Executive Officer and Director John R. Stuelpnagel - Chairman Benjamin J. Hindson - President Adam S. Taich - Chief Financial Officer Sridhar Kosaraju - Director Peer Information 10x Genomics (HLIS) 10x Genomics (AZTA) 10x Genomics (APYI) 10x Genomics (RNVA) 10x Genomics (HMSY) 10x Genomics (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 88025U109 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 126.96 Most Recent Split Date: (:1) Beta: 2.05 Market Capitalization: $3,006.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.24 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.82 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 58.74% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.69 Price/Cash Flow: - Price / Sales: 4.71 EPS Growth vs. Year Ago Period: 72.22% vs. Previous Quarter: 23.08% Sales Growth vs. Year Ago Period: -2.61% vs. Previous Quarter: -9.15% ROE 03/31/26 - -2.86 12/31/25 - -6.89 09/30/25 - -11.50 ROA 03/31/26 - -2.23 12/31/25 - -5.34 09/30/25 - -8.93 Current Ratio 03/31/26 - 5.90 12/31/25 - 4.46 09/30/25 - 4.48 Quick Ratio 03/31/26 - 5.42 12/31/25 - 4.09 09/30/25 - 4.06 Operating Margin 03/31/26 - -3.55 12/31/25 - -8.21 09/30/25 - -13.32 Net Margin 03/31/26 - -3.55 12/31/25 - -6.77 09/30/25 - -11.89 Pre-Tax Margin 03/31/26 - -3.01 12/31/25 - -6.21 09/30/25 - -11.39 Book Value 03/31/26 - 6.41 12/31/25 - 6.24 09/30/25 - 6.20 Inventory Turnover 03/31/26 - 3.23 12/31/25 - 3.04 09/30/25 - 2.77 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©